Renaissance Technologies
NSRX

Renaissance Technologies’s Nasus Pharma NSRX Stock Holding History

Renaissance Technologies’s Portfolio NSRX Stock Details NSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.7K Buy
+12,200
New +$35.7K ﹤0.01% 3060

Other funds holding NSRX

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Renaissance Technologies's NSRX Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Nasus Pharma (NSRX) in Q2 2026: 12,200 shares worth $42.7K. The stake represents ﹤0.01% of the portfolio and ranks #3060 among its holdings.

10 funds tracked by Wall St. Rank hold NSRX as of Q2 2026.

  • Renaissance Technologies held 12,200 shares of Nasus Pharma worth $42.7K as of Q2 2026.
  • Nasus Pharma was a new Renaissance Technologies position in Q2 2026.
  • Nasus Pharma made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3060 holding.
  • 10 funds tracked by Wall St. Rank held Nasus Pharma as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.